Integra lifesciences holdings corporation IART.US 總覽分析
IART 投資分析
看多重點:
- 價值≥4
- 股利≥2
分析結論
價值面評分優異,但股利評分未超過2分,若公司開始配息,可能會有更優異的投資結果
IART 近期報酬表現
1.26%
Integra lifesciences holdings corporation
1.31%
同產業平均
0.58%
S&P500
與 IART 同產業的標的表現
- TMCI Treace medical concepts inc價值 2 分趨勢 3 分波段 4 分籌碼 1 分股利 1 分查看更多
IART 公司資訊
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.